Transmissibility and abortogenic effect of equine viral arteritis in mares

A group of 14 pregnant mares was exposed via contact to 4 mares bred to stallions infected with equine viral arteritis virus. There was a demonstrable febrile response in each donor mare and in 12 of the pregnant mares. All 18 mares became seropositive after exposure. Equine viral arteritis virus was isolated from the nasopharynx of 5 pregnant mares, but not from the donor mares. Ten of the pregnant mares aborted, and virus was isolated from fetal specimens or placenta of 8.     

Physiological development of the equine fetus during late gestation

In many species, the pattern of growth and physiological development in utero has an important role in determining not only neonatal viability but also adult phenotype and disease susceptibility. Changes in fetal development induced by a range of environmental factors including maternal nutrition, disease, placental insufficiency and social stresses have all been shown to induce adult cardiovascular and metabolic dysfunction that often lead to ill health in later life. Compared to other precocious animals, much less is known about the physiological development of the fetal horse or the longer-term impacts on its phenotype of altered development in early life because of its inaccessibility in utero, large size and long lifespan. This review summaries the available data on the normal metabolic, cardiovascular and endocrine development of the fetal horse during the second half of gestation. It also examines the responsiveness of these physiological systems to stresses such as hypoglycaemia and hypotension during late gestation. Particular emphasis is placed on the role of the equine placenta and fetal endocrine glands in mediating the changes in fetal development seen towards term and in response to nutritional and other environmental cues. The final part of the review presents the evidence that the early life environment of the horse can alter its subsequent metabolic, cardiovascular and endocrine phenotype as well as its postnatal growth and bone development. It also highlights the immediate neonatal environment as a key window of susceptibility for programming of equine phenotype. Although further studies are needed to identify the cellular and molecular mechanisms involved, developmental programming of physiological phenotype is likely to have important implications for the health and potential athletic performance of horses, particularly if born with abnormal bodyweight, premature or dysmature characteristics or produced by assisted reproductive technologies, indicative of an altered early life environment.     

Immune potency of lyophilized, killed vaccine for equine viral arteritis and its protection against abortion in pregnant mares

Immune potency test was conducted in horses by inoculating a killed vaccine for equine viral arteritis (EVA) which had been freeze-dried and contained aluminum hydroxide adjuvant. Serum neutralizing (SN) antibody to equine arteritis virus (EAV) was detected at maximal titers of 1:80 to 1:640, 1 to 2 weeks after 2-dose vaccination of 6 female horses. However, 6 pregnant mares inoculated with the vaccine which had been kept in storage for 1 year at 4°C produced much higher titers ranging from 1:320 to 1:1280. A maximal mean titer of 1:199.5 occurred in the 1st and 2nd week after 2-dose inoculation with the nonpreserved vaccine, whereas a maximal mean titer of 1:794.3 occurred in the 2nd week using the preserved vaccine. The horses showed no systemic or local adverse reactions clinically or hematologically after vaccination. Four of the 6 vaccinated pregnant mares were exposed to the Bucyrus strain of EAV but resisted challenge exposure, while 3 nonvaccinated control pregnant mares revealed acute EVA causing abortion and death. Isolation of EAV was positive from the body tissues of the aborted and dead fetuses and their dams, but was negative from the vaccinated mares. No significant rise of SN antibody titers was detected in the vaccinated mares following challenge exposure, suggesting that the vaccine can protect against EAV infection in pregnant mares and prevent abortion or death.     

Lactation and reproductive performance of mares fed added dietary fat during late gestation and early lactation

Eighteen pregnant mares were randomly allotted to one of two treatment groups. The control group was fed a conventional concentrate and the fat group was fed a concentrate containing 5% feed-grade rendered fat. Both concentrates had the same nutrient:calorie ratio and were fed in amounts required to maintain zero change in percent body fat of the mares. During the study, which began 60 d prior to expected foaling date and ended 60 d postpartum, mares were monitored for feed intake, body weight, rump fat thickness, ration digestibility, plasma glucose and lipid concentrations, milk composition and reproductive efficiency. Birth weight, growth rate, and plasma glucose and lipid concentrations were also measured in foals. Mares fed fat consumed less concentrate (P<.09 during the last 60 d of gestation but consumed similar amounts of concentrate over 60 d of lactation. Protein and ether extract digestion was higher (P<.05 and P<.09, respectively) in the mares fed fat during the postpartum period. Dietary treatment had no influence on plasma glucose or lipid concentrations of the mares or plasma glucose concentrations of their foals, but foals whose dams were fed fat had higher plasma lipid concentrations at birth (P<.01), d 10 and d 30 (P<.05). Percent fat was higher in milk samples from mares fed fat at d 10 (P<.09, 1.23 vs .99%) and d 60 (P<.01, .72 vs .43%) of lactation. Reproductive performance was not significantly different between treatment groups, however there was a trend for a shorter postpartum interval and fewer cycles per pregnancy in the mares fed added fat. Foals from both groups were of similar size and weight at birth and had similar weight gains over 60 d, however, foals nursing mares fed fat tended to gain more weight in the first week of life (1.85 vs 1.56 kg/d) and have more rump fat at d 60 (.53 vs .44 cm) than foals nursing control mares.     

Effects of feeding sows fat or fructose during late gestation and lactation

The effects of dietary fat or fructose supplementation during late gestation and lactation on sow milk production and composition and on progeny were examined. On d 88 of gestation, 24 sows were allotted by parity to three dietary treatments (eight sows/treatment). Treatments were 1) a 12.5% crude protein, corn-soybean meal control, 2) the control + 10% added fat or 3) the control + 23% high fructose corn syrup. All treatments were fed to supply 1.82 kg/d of the control diet from d 89 of gestation to parturition with sows in treatments 2 or 3 receiving .18 kg of additional fat or .53 kg of additional high fructose corn syrup, respectively. Feed was gradually increased from d 1 to 7 of lactation to 4.54 kg/d of the control diet (plus .45 kg of added fat and 1.33 kg of added fructose for treatments 2 and 3) and remained at these levels for the remainder of the 21 d lactation period. All treatments were iso-nitrogenous; treatments 2 and 3 were iso-caloric. Litter birth weights, number of pigs born alive, weaning weights and piglet survival rate were not affected by sow treatment. Stillbirths were less (P less than .05) for sows fed fat. Lipid content of milk 24 h post-farrowing was greater (P less than .05) from sows fed fat compared with sows fed fructose. Milk production estimates indicated that multiparous sows fed fat produced more (P less .05) milk than sows fed the control diet. On d 112 of gestation and d 15 of lactation, serial blood samples were drawn to monitor sow response to a glucose challenge (1 g/kg body weight).(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of interval-feeding whole sunflower seeds during mid to late gestation on performance of beef cows and their progeny

This experiment was conducted to determine the effects of interval feeding of whole sunflower seeds on the performance of beef cows and their progeny. During mid to late gestation, 144 multiparous, spring-calving beef cows (588 kg of initial BW; 5.6 initial BCS; 4 to 13 yr old) were individually fed 1 of 3 supplements 4 d/wk for a 76-d period. Supplements (DM basis) included: 1) 0.68 kg of soybean meal/feeding (NCON); 2) 3.01 kg of a soybean hull-based supplement/feeding (PCON); and 3) 1.66 kg of whole sunflower seeds high in linoleic acid/feeding (WSUN). Supplements were formulated to provide similar amounts of CP and ruminally degraded intake protein; PCON and WSUN were also formulated to be isocaloric. During the supplementation period, cows had free-choice access to bermudagrass (Cynodon dactylon) and tall-grass prairie hay. By the end of the 76-d supplementation period, cows fed PCON (P < 0.01) and NCON (P < 0.01) had gained more BW than cows fed WSUN (33, 23, and 10 kg, respectively). However, from the end of this supplementation period to the beginning of the breeding season 84 d later, cows supplemented with PCON had lost more (P < 0.01) BW than cows supplemented with WSUN (-123 kg vs. -111 kg). Cow BW change through weaning (-50 kg, P = 0.43) and final cow BW (536 kg, P = 0.70) at weaning were not different among supplement groups. Furthermore, cow BCS was similar among supplement treatment groups at the end of the supplementation period (5.3, P = 0.09), at the beginning of the breeding season (4.8, P = 0.38), and at weaning (4.7, P = 0.08). No difference among treatments was detected for calf birth weight (36 kg, P = 0.42), calf weaning weight (235 kg, P = 0.67), percentage of cows exhibiting luteal activity at the beginning of the breeding season (57%, P = 0.29), or pregnancy rate (88%, P = 0.44). However, first service conception rate was greater (P = 0.01) for cows fed PCON (79%) and tended (P = 0.07) to be greater for cows fed WSUN (74%) than for cows fed NCON (53%). After weaning, all steer calves were placed in a feedlot and fed a high-concentrate finishing diet for an average of 188 d. Supplements fed to dams during gestation did not influence feedlot performance or carcass characteristics. Prepartum energy supplementation, regardless of energy source or prepartum energy balance, resulted in improved conception rate, but other measures of reproduction, calf and feedlot performance, and carcass characteristics were not affected.     

Review of two viral agents of economic importance to the equine industry (equine herpesvirus-1, and equine arteritis virus)

Equine herpesvirus type-1 (EHV-1) and equine arteritis virus (EAV) are infectious agents that cause serious health risks to horse populations and are disbursed worldwide, which can lead to significant financial losses. In addition to being responsible for abortion and neonatal death, these viruses are associated with respiratory illness. Although previous research and reviews have been written on these viruses, both viruses still affect horse populations around the world and the vaccines currently available are not completely protective, especially against EHV-1 and equine herpes myeloencephalopathy (EHM). Moreover, EAV is considered a threat to the $102 billion equine industry in the United States. As a result, these viruses represent a huge threat to the horse industry and efforts geared towards preventing the outbreak of the disease are strongly encouraged. For this reason, updates about these viruses are necessary and require more and more discussion on the nature and characteristics of these viruses to know how to overcome them. Prevention and control of abortion and neonatal foal death caused by each of the two viruses depend on appropriate management strategies coupled with prophylactic vaccination. This review presents the latest detailed information on EHV-1 and EAV from several aspects such as transmission, clinical signs, pathogenesis, latest developments on the treatment of the diseases, vaccination, and finally challenges and future perspectives. The information presented herein will be useful in understanding EHV-1 and EAV and formulating policies that can help to limit the spread of these viruses within horse populations.     

Serological surveillance of equine viral arteritis in the United Kingdom since the outbreak in 1993

Serological analysis of blood samples submitted to the Animal Health Trust showed that during 1995, 185 of 9203 unvaccinated horses (2.0 per cent) tested positive for antibodies to equine arteritis virus (EAV), and that during 1996, 46 of 8851 unvaccinated horses (0.52 per cent) tested positive. During both years thoroughbreds were the predominant breed tested and only a small proportion of these (<0.3 per cent), consisting predominantly of imported mares, were seropositive. In contrast, among standardbred horses, from which samples were actively solicited in 1995, 84 of 454 (18.5 per cent) were seropositive. Among standardbreds there was a difference in prevalence between types of horses, with 3.7 per cent of racing horses, 25 per cent of non-racing horses and 41 per cent of stallions testing seropositive. Investigations of seropositive stallions identified during 1994 and 1995 demonstrated that clinically inapparent equine viral arteritis (EVA) had occurred previously in the UK. Of 50 seropositive stallions, nearly half were standardbreds and nearly all had been imported from either North America or the European Union. Whether 34 seropositive stallions were shedding virus in their semen was established either by test mating, by the serology of the covered mares, or by investigation by MAFF following the introduction of the Equine Viral Arteritis Order 1995. Nine of the stallions (26.5 per cent) were identified as presumptive shedders of EAV in semen and among specific breeds, viral shedding was identified in six of 15 (40 per cent) standardbreds and three of nine (33 per cent) warmbloods. In contrast with the outbreak of EVA in the UK in 1993, no signs of disease typical of EAV infection were reported during these investigations, even in mares test mated to stallions shedding the virus.     

Evaluation of the safety of ivermectin-praziquantel administered orally to pregnant mares

OBJECTIVE: To evaluate the safety of an orally administered ivermectin and praziquantel paste with regard to variables associated with clinical findings, parturition, lactation, maternal care, and neonate viability in pregnant mares. ANIMALS: 40 pregnant mares. PROCEDURE: Mares were randomly allocated into treatment (n = 20) and control (20) groups and administered a placebo or 3 times the therapeutic dosage of ivermectin (0.6 mg/kg) and praziquantel (4.5 mg/kg) at 14-day intervals until parturition. Physical examinations were performed on mares and their foals after parturition (on postpartum days 30, 60, and 90) to identify any drug-related effects. As an aid in assessing general health, hematologic and serum biochemical analyses were performed monthly on the mares. RESULTS: In blood constituents, minor alterations that were not biologically important were observed. Reproductive performance was not affected by the unusual treatment duration or high dosage, although the drugs were administered during a crucial period of equine embryonic development (30 to 60 days). Neither adverse effects on mares nor abortions occurred. Follow-up evaluations of the foals for a 3-month period did not detect any abnormalities. CONCLUSIONS AND CLINICAL RELEVANCE: Administration of the ivermectin-praziquantel paste appears to be safe in pregnant mares and their foals.     

Changes in lymphocyte blastogenic response of mares during the perinatal period

A fluorometric assay was applied to evaluate blastogenesis of equine lymphocytes. Optimal culture conditions were as follows; concentrations of phytohaemagglutinin-P (PHA), concanavalin A (Con A) and pokeweed mitogen (PWM) were 1 microgram/ml, 40 micrograms/ml and 10 micrograms/ml, respectively, when 5 X 10(5) lymphocytes were incubated with culture medium containing 20% pooled horse serum (PHS) for 120 hours. The relative mean stimulation index of healthy non-pregnant mares were 5.107 +/- 0.323 (M +/- SE) with PHA, 4.019 +/- 0.183 with Con A and 3.610 +/- 0.131 with PWM. Sequentially the blastogenic responses of lymphocytes from twenty mares were observed during various stages of the perinatal period. Response decreased gradually before parturition was lowest at the time of parturition (PHA: 1.923 +/- 0.174, Con A: 1.698 +/- 0.206 and PWM: 1.706 +/- 0.177), and then increased gradually after parturition towards non-pregnant levels.     

Evaluation of the zootechnical parameters of vaccinating against swine enzootic pneumonia under field conditions

A field test was carried out in different production systems to evaluate the effect of vaccination against swine enzootic pneumonia with an inactivated vaccine. A total of 13,691 pigs of four different genetic origins were used, of which 7,351 were vaccinated and 6,340 were used as controls. The animals were housed in 16 fattening units, in which the 'one-site', 'two-site' and 'three-site' production systems were represented. There were the following statistically significant differences in favour of the vaccinated animals: a 1.89 per cent lower mortality (P<0.001), a 0.09 lower feed conversion ratio (P<0.030), a 3.12 per cent lower cost per kilogram gained in fattening (P<0.031), a 4.02 per cent lower cost per kilogram of carcase (P<0.018), a 3.77 per cent lower cost of feed per kilogram gained in fattening (P<0.012) and a 56.75 per cent lower potential loss of profit per kilogram gained in fattening due to mortality (P<0.001). An analysis of variance of the effects of genetic origin, treatment and production system on the different parameters showed that only the treatment had any statistically significant effect on the percentage mortality (P<0.002), feed conversion ratio (P<0.030), cost per kilogram gained in fattening (P<0.019), cost per kilogram of carcase (P<0.020), cost of feed per kilogram gained in fattening (P<0.015) and potential loss of profit per kilogram gained in fattening due to mortality (P<0.002).     

Equine viral arteritis: A respiratory and reproductive disease of significant economic importance to the equine industry

Equine arteritis virus is the causative agent of equine viral arteritis, a respiratory and reproductive disease that affects the members of the family Equidae. The virus was first isolated from the lung of an aborted fetus after an extensive outbreak of respiratory disease and abortion on a Standardbred breeding farm near Bucyrus, Ohio, in 1953. Since then, periodic outbreaks of equine viral arteritis have been reported in a number of countries around the world. This disease may result in significant economic loss to the equine industry due to the occurrence of abortion in pregnant mares, neonatal mortality, and establishment of the carrier state in stallions. This article provides an extensive review on equine arteritis virus, epidemiology, disease, pathogenesis, and prevention and control measures.     

Messenger RNA expression of angiotensin-converting enzyme, endothelin, cyclooxygenase-2 and prostaglandin synthases in bovine placentomes during gestation and the postpartum period

The bovine placenta contains local vasoactive-related systems, including angiotensin-converting enzyme (ACE), endothelin-1 (ET-1), ET-A receptor (ETAR) and ET-B receptor (ETBR), as well as arachidonic acid (AA) cascade-related enzymes, such as cyclooxygenase-2 (Cox-2), prostaglandin E-synthase (PGES) and prostaglandin F-synthase (PGFS). The mRNA expression of these molecules was examined in bovine placentomes (caruncles and cotyledons) collected immediately (0 h) and 6h after spontaneous parturition from 15 cows with early (fetal membranes released within 6 h of parturition) or late (fetal membranes released 6-12 h after parturition) detachment, as well as from 15 pregnant cows at a slaughterhouse. Significant differences were observed in expression of ET-1, ETAR and ETBR mRNAs between gestation and the postpartum period in both caruncles and cotyledons. Significant differences were also found between 0 and 6 h postpartum in the expression of ETBR mRNA in the early detachment group and PGES mRNA in the early and late detachment groups. Compared to PGFS, both Cox-2 and PGES exhibited opposite mRNA expression patterns during gestation and the postpartum period. The vasoactive-related peptide systems and AA cascade-related enzymes may mediate placental development and fetal membrane detachment after parturition in cattle.